(Q42675999)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23140991%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

title

Treatment of canine leishmaniosis with aminosidine at an optimized dosage regimen: a pilot open clinical trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23140991%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23140991%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

author name string

M N Saridomichelakis

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23140991%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

V I Kontos

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23140991%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

G Spanakos

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23140991%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

T S Rallis

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23140991%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

publication date

23 October 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23140991%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

published in

Veterinary Parasitology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23140991%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

volume

192

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23140991%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

issue

1-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23140991%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

page(s)

91-97

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23140991%20AND%20SRC:MED&resulttype=core&format=json

Effects of antimonial therapy for canine leishmaniasis on antibody titer.

17 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2012.10.011

Canine leishmaniasis: a diagnostic and clinical challenge.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2012.10.011

Pharmacokinetics and dosing regimen of aminosidine in the dog

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2012.10.011

The efficacy of enrofloxacin, alone or combined with metronidazole, in the therapy of canine leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2012.10.011

Clinical, serologic, and parasitologic follow-up after long-term allopurinol therapy of dogs naturally infected with Leishmania infantum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2012.10.011

Quantitation of amastigotes of Leishmania donovani in smears of splenic aspirates from patients with visceral leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2012.10.011

Initial and long-term efficacy of a lipid emulsion of amphotericin B desoxycholate in the management of canine leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2012.10.011

The role of dogs as reservoirs of Leishmania parasites, with emphasis on Leishmania (Leishmania) infantum and Leishmania (Viannia) braziliensis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2012.10.011

Short report: improved diagnosis and follow-up of canine leishmaniasis using amastigote-based indirect immunofluorescence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2012.10.011

Use of domperidone in the treatment of canine visceral leishmaniasis: a clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2012.10.011

Postantibiotic effect of aminoglycosides on gram-negative bacteria evaluated by a new method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2012.10.011

A randomised, blinded, placebo-controlled clinical trial with allopurinol in canine leishmaniosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2012.10.011

Rational dosing of antimicrobial drugs: animals versus humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2012.10.011

Studies on canine leishmaniasis control. 1. Evolution of infection of different clinical forms of canine leishmaniasis following antimonial treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2012.10.011

Comparison of different tissue sampling for PCR-based diagnosis and follow-up of canine visceral leishmaniosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2012.10.011

Study of efficacy of miltefosine and allopurinol in dogs with leishmaniosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2012.10.011

Serum concentrations of acute-phase proteins in dogs with leishmaniosis during short-term treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2012.10.011

Serum concentrations of acute phase proteins in dogs with leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2012.10.011

Canine leishmaniosis--new concepts and insights on an expanding zoonosis: part two.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2012.10.011

Multicentric, controlled clinical study to evaluate effectiveness and safety of miltefosine and allopurinol for canine leishmaniosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2012.10.011

Canine leishmaniasis: epidemiological risk and the experimental model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2012.10.011

Treatment of canine Old World visceral leishmaniasis: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2012.10.011

Comparative efficacy of meglumine antimoniate and aminosidine sulphate, alone or in combination, in canine leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2012.10.011

Guidelines for treatment of leishmaniasis in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2012.10.011

Clinical and serological follow-up in dogs with visceral leishmaniosis treated with allopurinol and sodium stibogluconate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2012.10.011

Comparison of aminosidine (paromomycin) and sodium stibogluconate for treatment of canine leishmaniasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2012.10.011

Chronic hepatitis associated with canine leishmaniosis (Leishmania infantum): a clinicopathological study of 26 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2012.10.011

Advances in the pathogenesis of canine leishmaniosis: epidemiologic and diagnostic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2012.10.011

The effect of intravenous or subcutaneous administration of meglumine antimonate (Glucantime) in dogs with leishmaniasis. A randomized clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2012.10.011

Directions for the diagnosis, clinical staging, treatment and prevention of canine leishmaniosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2012.10.011

Development of a PCR-based method for diagnosis of Leishmania in blood samples

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2012.10.011

Injectable paromomycin for Visceral leishmaniasis in India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2012.10.011

Long term follow-up of dogs diagnosed with leishmaniosis (clinical stage II) and treated with meglumine antimoniate and allopurinol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2012.10.011

Pharmacokinetic/pharmacodynamic integration in drug development and dosage-regimen optimization for veterinary medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2012.10.011

Pharmacokinetics of meglumine antimoniate after administration of a multiple dose in dogs experimentally infected with Leishmania infantum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2012.10.011

Clinical recovery and limited cure in canine visceral leishmaniasis treated with aminosidine (paromomycin).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2012.10.011

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VETPAR.2012.10.011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23140991%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

1 reference